NXXT compared with VVOS: revenue, margins and what each company keeps, and the suppliers and customers both name

NXXTNextnrg, Inc.

Mkt capRevenueRevenue

VVOSVivos Therapeutics, Inc.

Mkt capRevenueRevenue

Compare

NXXTNextnrg, Inc.

VVOSVivos Therapeutics, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Revenue flow

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Price

Supply-chain overlap

Revenue flow

NXXT: latest quarter is a loss; flow not drawable. VVOS: latest quarter is a loss; flow not drawable.Method ›

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

No disclosed counterparties: NXXT, VVOS.

Role chip = supplier or customerSource: SEC EDGAR

NXXTNextnrg, Inc.

2.68▼−2.56%

Mkt cap$4.6MRevenue$28MQ2 FY26Revenue—

VVOSVivos Therapeutics, Inc.

0.110.00%

Regular sessionSep 2 '83

Mkt cap$2.3MRevenue$5MQ2 FY26Revenue$17MFY25

Compare

Regular sessionSep 2 '83

NXXTNextnrg, Inc.

VVOSVivos Therapeutics, Inc.

2.68▼−2.56%

Price

0.110.00%

$4.6M

Mkt cap

$2.3M

Q2 FY26$28M

Revenue

$5MQ2 FY26

—

Revenue

$17MFY25

NXXT2.68▼−2.56%vsVVOS0.110.00%Regular sessionSep 2 '83

Price

rebased to 0%

NXXT, solidVVOS, dashed